CAS 13184-27-5

Carbamoylaspartic acid

Description:

Carbamoylaspartic acid, with the CAS number 13184-27-5, is an amino acid derivative characterized by the presence of both a carbamoyl group and an aspartic acid backbone. This compound features a carboxylic acid functional group, an amino group, and a carbamoyl group, which contributes to its unique properties. It is typically classified as a non-proteinogenic amino acid, meaning it is not incorporated into proteins during translation. Carbamoylaspartic acid is known for its potential biological significance, particularly in metabolic pathways and as a precursor in the synthesis of other biomolecules. Its solubility in water is notable, which facilitates its interaction in biological systems. The compound may exhibit various physiological effects, although specific biological activities can vary based on concentration and environmental conditions. As with many amino acids and their derivatives, it may participate in various biochemical reactions, making it of interest in both research and potential therapeutic applications.

Formula: C₅H₈N₂O₅

InChI: InChI=1S/C5H8N2O5/c6-5(12)7-2(4(10)11)1-3(8)9/h2H,1H2,(H,8,9)(H,10,11)(H3,6,7,12)/t2-/m0/s1

InChI key: InChIKey=HLKXYZVTANABHZ-REOHCLBHSA-N

SMILES: [C@@H](CC(O)=O)(NC(N)=O)C(O)=O

Synonyms:

• (2S)-2-(Carbamoylamino)butanedioic acid
• <span class="text-smallcaps">L</span>-Aspartic acid, N-(aminocarbonyl)-
• <span class="text-smallcaps">L</span>-Ureidosuccinic acid
• Aspartic acid, N-carbamoyl-, <span class="text-smallcaps">L</span>-
• Carbamoyl-L-Aspartic Acid Magnesium Salt
• Carbamoylaspartic acid
• Carbamoylasparticacid
• Carbamylaspartic acid
• Carbamylasparticacid
• L-Asparticaci
• L-Ureidosuccinicacid
• N-(Aminocarbonyl)-<span class="text-smallcaps">L</span>-aspartic acid
• N-(Aminocarbonyl)-L-Asparticaci
• N-Carbamoyl-(S)-aspartic acid
• N-Carbamoyl-<span class="text-smallcaps">L</span>-aspartic acid
• N-Carbamylaspartic acid
• N-carbamoyl-L-aspartic acid
• N-carbamoylaspartic acid
• NSC 14983
• Aspartic acid, N-carbamoyl-, L-
• L-Aspartic acid, N-(aminocarbonyl)-
• N-(Aminocarbonyl)-L-aspartic acid

Carbamoyl-Asp-OH · magnesium salt/Carbamoyl-Asp-OH · dipotassium salt (1:1)

CAS: 13184-27-5

Substrate for the determination of E.coli dihydroorotase (EC 3.5.2.3.), which catalyzes the cyclization of carbamoyl-Asp-OH into L-5,6-dihydroorotate. This enzyme being in the biosynthetic pathway of pyrimidine nucleotides, is an important therapeutic target for the design of new antineoplastic agents. Its activity was assayed spectrophotometrically measuring the increase of absorbance at 230 nm (ε₂₃₀ = 1170 M⁻¹cm⁻¹, Km = 0.47 mM, kcat = 143 s⁻¹).

Formula: C₁₀H₁₂K₂MgN₄O₁₀

Purity: > 90%

Color and Shape: White Powder

Molecular weight: 450.73

Ref: 01-4027537

N-Carbamoyl-L-aspartic acid

CAS: 13184-27-5

N-Carbamoyl-L-aspartic acid

Purity: ≥95%

Molecular weight: 176.13g/mol

Ref: 54-OR1005068

N-Carbamoyl-L-aspartic acid

CAS: 13184-27-5

Purity: 98%

Molecular weight: 176.04

Ref: 10-F557449

Carbamoyl-Asp-OH·magnesium salt/Carbamoyl-Asp-OH·dipotassium salt (1:1)

CAS: 13184-27-5

Carbamoyl-Asp-OH·magnesium salt/Carbamoyl-Asp-OH·dipotassium salt (1:1) is a derivate of p-hydroxybenzoic acid that has been shown to inhibit leukotriene receptor antagonists and basic proteins. It has been found in urine samples, but its function is not yet known. The uptake of this molecule may be a potential biomarker for the diagnosis of orotic aciduria and HIV infection. Carbamoyl-Asp-OH·magnesium salt/Carbamoyl-Asp-OH·dipotassium salt (1:1) has also been shown to be an inhibitor of intramolecular hydrogen transfer reactions in model systems.

Formula: C₁₀H₁₂K₂MgN₄O₁₀

Purity: Min. 95%

Molecular weight: 450.72 g/mol

Ref: 3D-FC110933